Condition
Glaucoma, Congenital
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Enrolling By Invitation1
Terminated1
Unknown1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03016156Not ApplicableTerminated
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
NCT04947124Phase 2Completed
A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101
NCT04381611Enrolling By Invitation
INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
NCT05011747Not ApplicableUnknownPrimary
Viscotrabeculotomy in Pediatric Glaucoma Following Cataract Surgery
Showing all 4 trials